GLUT3
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer (NCT04516681) | Fudan University | 2024-12-01 |
Track GLUT3 automatically
Every clearance here is in the API, with alerts when new ones post.